Low molecular weight heparins--a safer option than unfractionated heparin?
McKay
G A
GA
Wolfson Unit of Clinical Pharmacology, University of Newcastle Upon Tyne, Newcastle upon Tyne, NE1 7RU.
Paterson
K R
KR
D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D013921:Thrombocytopenia / Q000139:chemically induced
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin